http://jcps.bjmu.edu.cn

• 研究论文 • 上一篇    下一篇

14β-侧链紫杉醇类似物的合成

尹大力, 刘瑞武, 王东辉, 郭积玉, 梁晓天*, 关口喜功, 龟尾一弥   

  1. 1.中国医学科学院中国协和医科大学药物研究所, 北京 100050
    2.大正制药株式会社, 日本 琦玉 330
  • 收稿日期:1998-12-14 修回日期:1999-06-03 出版日期:1999-12-15 发布日期:1999-12-15
  • 通讯作者: 梁晓天*

Synthesis of Analogues of Paclitaxel with 14β-Side Chain from Sinenxan A

Yin Dali, Liu Ruiwu, Wang Donghui, Guo Jiyu, Liang Xiaotian*, Yoshinori Sekiguchi, Kazuya Kameo   

  1. 1.Institute of Materia Medica, China Academy of Medical Sciences acd Peking Union Medical College, Beijing 100050;
    2.Taisho Pharmaceutical Co.Lid 403 Youshion-Cho 1-Chome Ohmiya-shi, Saitama, 330, Japan
  • Received:1998-12-14 Revised:1999-06-03 Online:1999-12-15 Published:1999-12-15
  • Contact: Liang Xiaotian*

摘要: SinenxanA(2)是一从红豆杉组织培养物中分离得到的具有紫杉醇母核A/B/C环骨架的化合物。以该化合物为起始原料, 通过4,20-双键合成D-, 14β-位引入侧链等合成了1,7,9,13-脱氧-14β-侧链紫杉醇类似物45。这两个化合物在体外活性实验中, KB, A2780HCT-8细胞株的细胞毒性比紫杉醇显著降低; 10μmol·L-1浓度下对微管蛋白聚合没有作用。

关键词: Sinenxan A, C-14β侧链紫杉醇类似物, 半合成

Abstract: Sinenxan A (2), isolated from tissue culture, possesses an A/B/C ring skeletonwithout 1,7,9,13-oxygen functionality of paclitaxel (1). Two 1,7,9,13-deoxy, C-14β side chain analogues 4 and 5 of 1 were synthesized from 2 by incorporating the 4,20-double bond into the D-ring and introducing the side chain at 14β position. Compounds 4 and 5 showed significantly decreasedactivity in the cytotoxicity assay in vitro against KB, A2780, and HCT-8. In tubulin assembly assaythey did not show any activity at 10 μmol.L-1.

Key words: Sinenxan A, Sinenxan A, C-14β side chain paclitaxel analogues, C-14β side chain paclitaxel analogues, Semisynthesis, Semisynthesis

Supporting: